Drug
Kpl 914
Kpl 914: highest development phase Phase 2, developed by Kiniksa Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Kiniksa Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| KPL-914 NCT03980522 | Phase 2 | Recurrent Pericarditis |
Latest
No recent events.
Follow Kpl 914 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.